Travere Therapeutics, Inc. (TVTX)
44.74
+1.25
(+2.87%)
USD |
NASDAQ |
May 21, 16:00
44.71
-0.03
(-0.07%)
After-Hours: 19:59
Travere Therapeutics Research and Development Expense (TTM) : 216.22M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Revolution Medicines, Inc. | 1.117B |
| AbbVie, Inc. | 9.501B |
| Mirum Pharmaceuticals, Inc. | 237.68M |
| Anika Therapeutics, Inc. | 26.42M |
| BioCryst Pharmaceuticals, Inc. | 187.06M |